By enabling real-time, population-aware interrogation of PI3K pathway biology, AI-HOPE-PI3K supports precision oncology efforts aimed at identifying clinically actionable biomarkers and reducing the disproportionate health burdens in CRC outcomes. The gene discussed is PIK3CA; the disease is colorectal carcinoma.